Humanwell Healthcare Group Co Ltd Market Cap ($4.66 Billion)

$4.66 Billion USD · CN¥31.84 Billion CNY · Rank #3623

Market Cap & Net Worth: Humanwell Healthcare Group Co Ltd (600079)

Humanwell Healthcare Group Co Ltd market cap. Humanwell Healthcare Group Co Ltd (SHG:600079) has a market capitalization of $4.66 Billion (CN¥31.84 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #3623 globally and #469 in its home market, demonstrating a 0.31% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Humanwell Healthcare Group Co Ltd's stock price CN¥19.51 by its total outstanding shares 1632225965 (1.63 Billion). Also see Humanwell Healthcare Group Co Ltd cash flow conversion for how efficiently the company converts equity into cash flow.

Humanwell Healthcare Group Co Ltd Market Cap History (2015–2026)

Humanwell Healthcare Group Co Ltd market cap history from 2015 to 2026. Data shows growth from $5.09 Billion to $4.66 Billion (0.82% CAGR). Check today's stock price for Humanwell Healthcare Group Co Ltd for real-time trading data and today's change.

Humanwell Healthcare Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Humanwell Healthcare Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Humanwell Healthcare Group Co Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.18x

Humanwell Healthcare Group Co Ltd's market cap is 0.18 times its annual revenue

Industry average: 0.59x Lower than industry average

Latest Price to Earnings (P/E) Ratio

2.33x

Humanwell Healthcare Group Co Ltd's market cap is 2.33 times its annual earnings

Industry average: 13.72x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$4.59 Billion	$12.33 Billion	$832.40 Million	0.37x	5.51x
2017	$4.12 Billion	$15.45 Billion	$2.07 Billion	0.27x	1.99x
2018	$2.37 Billion	$18.63 Billion	-$2.36 Billion	0.13x	N/A
2019	$3.16 Billion	$21.81 Billion	$842.54 Million	0.15x	3.75x
2020	$7.94 Billion	$20.68 Billion	$1.01 Billion	0.38x	7.90x
2021	$5.30 Billion	$20.55 Billion	$1.32 Billion	0.26x	4.03x
2022	$5.67 Billion	$22.34 Billion	$2.48 Billion	0.25x	2.28x
2023	$5.94 Billion	$24.52 Billion	$2.13 Billion	0.24x	2.78x
2024	$5.58 Billion	$25.44 Billion	$1.33 Billion	0.22x	4.20x
2025	$4.33 Billion	$23.96 Billion	$1.86 Billion	0.18x	2.33x

Competitor Companies of 600079 by Market Capitalization

Companies near Humanwell Healthcare Group Co Ltd in the global market cap rankings as of November 8, 2026. Also see 600079 total asset value for a full breakdown of the balance sheet.

Key companies related to Humanwell Healthcare Group Co Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#511	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#530	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$46.61
#567	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$47.07 Billion	CN¥50.43
#609	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.80

Market Capitalization of Humanwell Healthcare Group Co Ltd (2015–2026)

Market capitalization of Humanwell Healthcare Group Co Ltd from 2015 to today. Between 2015 and today, Humanwell Healthcare Group Co Ltd's market cap moved from $5.09 Billion to $ 4.66 Billion, with a yearly change of 0.82%.

Year	Market Cap	Change (%)
2026	CN¥4.66 Billion	+7.73%
2025	CN¥4.33 Billion	-22.54%
2024	CN¥5.58 Billion	-5.95%
2023	CN¥5.94 Billion	+4.71%
2022	CN¥5.67 Billion	+6.94%
2021	CN¥5.30 Billion	-33.25%
2020	CN¥7.94 Billion	+151.17%
2019	CN¥3.16 Billion	+33.23%
2018	CN¥2.37 Billion	-42.44%
2017	CN¥4.12 Billion	-10.06%
2016	CN¥4.59 Billion	-9.87%
2015	CN¥5.09 Billion	--

End of Day Market Cap According to Different Sources

On Nov 7th, 2026 the market cap of Humanwell Healthcare Group Co Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$4.66 Billion USD
MoneyControl	$4.66 Billion USD
MarketWatch	$4.66 Billion USD
marketcap.company	$4.66 Billion USD
Reuters	$4.66 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic

Market Cap

$4.66 Billion

CN¥31.84 Billion CNY

Market Cap Rank

#3623 Global

#469 in China

Share Price

CN¥19.51

Change (1 day)

+0.15%

52-Week Range

CN¥16.37 - CN¥20.82

All Time High

CN¥37.30